Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) anticorps

N° du produit ABIN7598062

L’anticorps Humanized Chimeric anti-ErbB2/Her2 (Trastuzumab Biosimilar) a été validé pour . Il convient pour détecter ErbB2/Her2 (Trastuzumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) anticorps (ABIN7598062)

Antigène: ErbB2/Her2 (Trastuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Chimeric

Conjugué: Cet anticorp ErbB2/Her2 (Trastuzumab Biosimilar) est non-conjugé

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-ErbB2/Her2 (Trastuzumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Research Grade Trastuzumab Biosimilar Antibody

Specificité: P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein

Purification: Protein A or G purified from cell culture supernatant.

Pureté: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 2.6 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Date de péremption: 12 months

Détails sur ErbB2/Her2 (Trastuzumab Biosimilar)

Antigène: ErbB2/Her2 (Trastuzumab Biosimilar)

Autre désignation: Trastuzumab Biosimilar

Classe de substances: Biosimilar

Sujet: P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein

UniProt: P04626

Numéro CAS: 180288-69-1